1 active not recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
Follow Unresectable Salivary Gland Squamous Cell Carcinoma: new trials by email Literature Review of Unresectable Salivary Gland Squamous Cell Carcinoma trials Research Report on Unresectable Salivary Gland Squamous Cell Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer Biospecimen Collection, Computed Tomography, Elimusertib - Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 7 | 2022-07-06 | 2026-08-21 |
Carcinoma (1) · Hypopharyngeal Neoplasms (1) · Laryngeal Neoplasms (1) · Mouth Neoplasms (1) · Oropharyngeal Neoplasms (1) · Salivary Gland Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1)
Carcinoma, Squamous Cell (1) · Head and Neck Neoplasms (1) · Laryngeal Diseases (1) · Mouth Diseases (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Glandular and Epithelial (1) · Otorhinolaryngologic Diseases (1) · Otorhinolaryngologic Neoplasms (1) · Pharyngeal Diseases (1) · Pharyngeal Neoplasms (1) · Respiratory Tract Diseases (1) · Respiratory Tract Neoplasms (1) · Salivary Gland Diseases (1)
BAY 1895344 (1) · Magnetic Resonance Spectroscopy (1) · Radiosurgery (1) · Specimen Handling (1) · pembrolizumab (1)
National Cancer Institute (NCI) (1)
United States (1)
Yvonne M Mowery (1)
UM1CA186690 (1)